Vote Scores
Filings read through

Praxis Precision Medicines, Inc.: how funds voted at the meeting of 26 Jun 2025

Ticker
PRAX
Meeting
Season
year to 30 June 2025
Filers reporting
258
Ballot items
3

258 filers on Form N-PX reported votes at the Praxis Precision Medicines, Inc. meeting of 26 Jun 2025. The records fall into 3 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Praxis Precision Medicines, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 81.3% of the reported votes are for. 36 filers withheld from or voted against at least one nominee.

    286 vote records from 86 filers. 4 of the 86 filers that marked the item voted against management.

    • Positions of 30 fund families
    • For 17
    • Abstain or withhold 1
    • Split or no vote 12
    • Against management 1
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    345 vote records from 258 filers. 189 of the 251 filers that marked the item voted against management. 7 filers gave no management mark.

    • Positions of 38 fund families
    • For 4
    • Against 34
    • Against management 34
  3. Item 3: Audit-related items (auditor ratification)

    142 vote records from 85 filers. 1 of the 85 filers that marked the item voted against management.

    • Positions of 30 fund families
    • For 30

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Praxis Precision Medicines, Inc., meeting of 26 Jun 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinAgainst, against managementNo report
American CenturyAgainst, against managementFor
BairdAgainst, against managementNo report
BlackRock and iSharesAgainst, against managementFor
BNY MellonForNo report
Brighthouse FundsAgainst, against managementFor
Charles SchwabAgainst, against managementFor
Columbia ThreadneedleAgainst, against managementFor
DWSAgainst, against managementFor
EquitableAgainst, against managementFor
FidelityAgainst, against managementFor
Franklin TempletonAgainst, against managementFor
Global XAgainst, against managementFor
Goldman SachsAgainst, against managementFor
Guggenheim and RydexAgainst, against managementFor
InvescoAgainst, against managementFor
J.P. MorganAgainst, against managementNo report
Janus HendersonForFor
John Hancock and ManulifeAgainst, against managementFor
Lincoln FinancialForFor
MassMutualAgainst, against managementFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementFor
NationwideAgainst, against managementFor
Natixis and Loomis SaylesAgainst, against managementNo report
Neuberger BermanAgainst, against managementNo report
Northern Trust and FlexSharesAgainst, against managementFor
Nuveen and TIAAAgainst, against managementFor
Pacific Life fundsAgainst, against managementFor
PGIM and PrudentialAgainst, against managementNo report
PrincipalAgainst, against managementNo report
ProShares and ProFundsAgainst, against managementFor
SEIAgainst, against managementFor
State Street and SPDRForFor
T. Rowe PriceAgainst, against managementFor
TransamericaAgainst, against managementFor
VanguardAgainst, against managementFor
Victory CapitalAgainst, against managementFor
VoyaAgainst, against managementFor

Questions

How many filers reported votes at the Praxis Precision Medicines, Inc. meeting?
258 Form N-PX filers reported votes at the meeting of 26 Jun 2025. On say-on-pay, 189 of 251 filers that marked the item voted against management (75.3%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Praxis Precision Medicines, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Praxis Precision Medicines, Inc. with a meeting date within three days of 26 Jun 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .